These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8276294)

  • 1. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
    Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E
    Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.
    Karlan BY; Hawkins R; Hoh C; Lee M; Tse N; Cane P; Glaspy J
    Gynecol Oncol; 1993 Nov; 51(2):175-81. PubMed ID: 8276290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].
    Römer W; Avril N; Dose J; Ziegler S; Kuhn W; Herz M; Jänicke F; Schwaiger M
    Rofo; 1997 Jan; 166(1):62-8. PubMed ID: 9072107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study.
    Carretta A; Landoni C; Melloni G; Ceresoli GL; Compierchio A; Fazio F; Zannini P
    Eur J Cardiothorac Surg; 2000 Apr; 17(4):377-83. PubMed ID: 10773558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
    Yuan CC; Liu RS; Wang PH; Ng HT; Yeh SH
    J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative assessment of asymptomatic adnexal tumors by positron emission tomography and F 18 fluorodeoxyglucose].
    Fenchel S; Kotzerke J; Stöhr I; Grab D; Nüssle K; Rieber A; Kreienberg R; Brambs HJ; Reske SN
    Nuklearmedizin; 1999; 38(4):101-7. PubMed ID: 10392374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
    Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
    Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker.
    Chang WC; Hung YC; Kao CH; Yen RF; Shen YY; Lin CC
    Neoplasma; 2002; 49(5):329-33. PubMed ID: 12458332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
    Bohdiewicz PJ; Juni JE; Ball D; Dworkin H
    Clin Nucl Med; 1995 May; 20(5):419-20. PubMed ID: 7628145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Wahl RL; Cody RL; Hutchins GD; Mudgett EE
    Radiology; 1991 Jun; 179(3):765-70. PubMed ID: 2027989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
    Inokuma T; Tamaki N; Torizuka T; Magata Y; Fujii M; Yonekura Y; Kajiyama T; Ohshio G; Imamura M; Konishi J
    Radiology; 1995 May; 195(2):345-52. PubMed ID: 7724751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ; Maisey MN; Fogelman I
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.